Status:
TERMINATED
Suboptimal Weight Loss After Gastric Bypass Surgery
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
St. Olavs Hospital
Conditions:
Obesity, Morbid
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
Bariatric surgery is the only long-term established treatment for morbid obesity. However, some patients experience suboptimal weight loss after surgery and/or experience a significant weight regain. ...
Eligibility Criteria
Inclusion
- Body mass index (BMI) \>40kg/m2, or BMI\>35kg/m2 with comorbidities
- healthy volunteers with suboptimal weight loss
- health with significant weight regain after Roux-n-Y Gastric Bypass, defined as failure to lose at least 40% Excess Weight Loss by 12 months postoperatively.
- Significant weight regain: Regain of ≥15% of total weight lost after the first postoperative year.
Exclusion
- Pregnancy
- enrollment in another obesity treatment
- previous revisional bariatric surgery
- planned bariatric surgery
- past or ongoing drug or alcohol abuse
- physical or mental impairment that interferes with the ability to comply to treatment
- history of severe psychological disorder
- history of severe eating disorder
- current medication known to affect appetite or induce weight loss
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT01829906
Start Date
August 1 2013
End Date
August 1 2014
Last Update
October 4 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Olavs Hospital
Trondheim, Norway